# Clinical Experience With Sparsentan in Switzerland in IgA Nephropathy

> **NCT07555301** · — · NOT_YET_RECRUITING · sponsor: **Waid City Hospital, Zurich** · enrollment: 50 (estimated)

## Conditions studied

- IgA Nephropathy (IgAN)

## Interventions

- **DRUG:** sparsentan
- **DRUG:** sparsentan

## Key facts

- **NCT ID:** NCT07555301
- **Lead sponsor:** Waid City Hospital, Zurich
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2028-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07555301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07555301, "Clinical Experience With Sparsentan in Switzerland in IgA Nephropathy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07555301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*